These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Eplerenone: a selective aldosterone receptor antagonist for patients with heart failure. Barnes BJ; Howard PA Ann Pharmacother; 2005 Jan; 39(1):68-76. PubMed ID: 15590870 [TBL] [Abstract][Full Text] [Related]
3. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure. Moore TD; Nawarskas JJ; Anderson JR Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934 [TBL] [Abstract][Full Text] [Related]
4. Eplerenone: a selective aldosterone receptor antagonist (SARA). Delyani JA; Rocha R; Cook CS; Tobert DS; Levin S; Roniker B; Workman DL; Sing YL; Whelihan B Cardiovasc Drug Rev; 2001; 19(3):185-200. PubMed ID: 11607037 [TBL] [Abstract][Full Text] [Related]
5. Eplerenone: a selective aldosterone blocker. Stier CT Cardiovasc Drug Rev; 2003; 21(3):169-84. PubMed ID: 12931252 [TBL] [Abstract][Full Text] [Related]
6. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure. McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762 [TBL] [Abstract][Full Text] [Related]
7. The cardiovascular effects of eplerenone, a selective aldosterone-receptor antagonist. Davis KL; Nappi JM Clin Ther; 2003 Nov; 25(11):2647-68. PubMed ID: 14693297 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the aldosterone-blocking agent eplerenone in hypertension and heart failure. George J; Struthers AD Expert Opin Pharmacother; 2007 Dec; 8(17):3053-9. PubMed ID: 18001264 [TBL] [Abstract][Full Text] [Related]
14. A comparison of the aldosterone-blocking agents eplerenone and spironolactone. Struthers A; Krum H; Williams GH Clin Cardiol; 2008 Apr; 31(4):153-8. PubMed ID: 18404673 [TBL] [Abstract][Full Text] [Related]
15. Aldosterone antagonists in heart failure. Guglin M; Kristof-Kuteyeva O; Novotorova I; Pratap P J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):150-9. PubMed ID: 21160084 [TBL] [Abstract][Full Text] [Related]
16. Eplerenone: a review of its use in essential hypertension. Croom KF; Perry CM Am J Cardiovasc Drugs; 2005; 5(1):51-69. PubMed ID: 15631538 [TBL] [Abstract][Full Text] [Related]
17. Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone. Lainscak M; Pelliccia F; Rosano G; Vitale C; Schiariti M; Greco C; Speziale G; Gaudio C Int J Cardiol; 2015 Dec; 200():25-9. PubMed ID: 26404748 [TBL] [Abstract][Full Text] [Related]